olanzapine   Click here for help

GtoPdb Ligand ID: 47

Synonyms: LY-170053 | Zyprexa®
Approved drug
olanzapine is an approved drug (EMA & FDA (1996))
Compound class: Synthetic organic
Comment: Olanzapine displays affinity for numerous receptors from the serotonin, histamine, alpha adrenergic, dopamine and muscarinic acetylcholine receptor families. Its antipsychotic properties are believed to arise from its antagonism of the dopamine D2 and 5-HT2A receptors.
Marketed formulations may contain olanzapine pamoate (PubChem CID 12085238). Olanzapine is represented on some databases with some of the double bonds in a different position. See CHEBI:7735 and CHEMBL715.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: olanzapine

olanzapine is commercially available from our sponsors

2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 1
Topological polar surface area 59.11
Molecular weight 312.14
XLogP 2.79
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
Isomeric SMILES CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C
InChI InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,18H,7-10H2,1-2H3
InChI Key WXPNDRBBWZMPQG-UHFFFAOYSA-N
Bioactivity Comments
In vivo and in vitro studies in rats have indicated that antagonism of α1A-AR by olanzapine is responsible for the side effect of orthostatic hypotension associated with this drug [8].
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
α1A-adrenoceptor Rn Antagonist Antagonist 7.4 pA2 - 8
⤷ pA2 7.4 [8]
Description: Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
α1D-adrenoceptor Rn Antagonist Antagonist 6.4 pA2 - 8
⤷ pA2 6.4 [8]
Description: Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat aorta.
H1 receptor Hs Antagonist Antagonist 8.7 – 9.2 pKi - 6,11
⤷ pKi 8.7 – 9.2 [6,11]
5-HT2A receptor Primary target of this compound Hs Antagonist Antagonist 8.6 – 8.9 pKi - 4,6,11-12
⤷ pKi 8.6 – 8.9 [4,6,11-12]
D2 receptor Primary target of this compound Hs Antagonist Antagonist 8.7 pKi - 1
⤷ pKi 8.7 (Ki 2.1x10-9 M) [1]
5-HT2C receptor Primary target of this compound Hs Antagonist Inverse agonist 8.1 – 8.4 pKi - 2,6,12
⤷ pKi 8.1 – 8.4 [2,6,12]
5-HT6 receptor Rn Antagonist Inverse agonist 7.6 – 8.6 pKi - 5,10
⤷ pKi 7.6 – 8.6 [5,10]
5-HT6 receptor Hs Antagonist Inverse agonist 8.0 pKi - 3,9
⤷ pKi 8.0 [3,9]
5-HT7 receptor Rn Antagonist Antagonist 6.8 – 7.0 pKi - 5,10
⤷ pKi 6.8 – 7.0 [5,10]
5-HT1F receptor Hs Agonist Full agonist 6.5 pKi - 11
⤷ pKi 6.5 [11]
5-HT7 receptor Hs Antagonist Antagonist 6.5 pKi - 13
⤷ pKi 6.5 [13]
5-HT1B receptor Hs Agonist Full agonist 6.3 pKi - 11
⤷ pKi 6.3 [11]
5-HT1D receptor Hs Agonist Full agonist 6.2 pKi - 11
⤷ pKi 6.2 [11]
5-HT1A receptor Hs Agonist Full agonist 5.6 – 5.8 pKi - 7,11
⤷ pKi 5.6 – 5.8 [7,11]
5-ht1e receptor Hs Agonist Full agonist 5.7 pKi - 11
⤷ pKi 5.7 [11]